Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today. Total revenues increased 8% year-over-year to $12 billion,...
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The...
Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year....
The IPO market is recovering from the slowdown experienced towards the end of 2021, with pharma companies dominating the scene...
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant...
The pharma sector has been on a stable growth trajectory lately, and the trend gathered momentum when the pandemic-related emergency...
Tilray (NASDAQ: TLRY) reported second-quarter 2022 financial results before the regular market hours on Monday. Total net revenue increased 20%...
Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q1 2022 earnings call dated Jan. 06, 2022, Call participants: Tiffany Kanaga — Vice...
There are quite a few pharmaceutical companies lined up to make their market debut this week. Among these is Amylyx...
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering...
As the first week of the new year slowly unfolds, it appears the pharmaceutical industry is taking the front seat...
The healthcare sector, led by pharmaceutical and biotechnology firms, has contributed significantly to the IPO boom that sent the market...
Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States. Founded in...
Eli Lilly and Company (NYSE: LLY) reported revenue of $6.7 billion for the third quarter of 2021, up 18% year-over-year....
After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of...
Biofrontera Inc (NASDAQ: BFRI) Q3 2021 earnings call dated Nov. 30, 2021 Corporate Participants: Pamela Keck — Head of Investor Relations...
Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to...
Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom...
Pfizer delivered a solid performance in Q3 2021 with a triple-digit increase in revenue and profits growing many-fold. The company’s...
Aurora Cannabis, Inc. (NYSE: ACB) on Tuesday reported a loss for the first quarter of 2022 when its revenues declined...
